This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eli Lilly & Company
Drug Names(s): Insulin lispro injection, HumaPen MEMOIR, HumaPen LUXURA HD, LY275585, Humalog U-200
Description: Humalog is a mealtime insulin. Humalog is absorbed quickly and starts working within minutes to lower blood sugar.
Revenue for Humalog and all Humalog products, including Humalog Mix, are included under Humalog.
Eli Lilly also developed Humalog Mix 75/25. This formulation contains 75% of insulin lispro protamine (intermediate acting insulin) and 25% of insulin lispro (fast acting insulin). Therefore, this formulation aims to better control blood sugar.
Lilly also developed HumaPen MEMOIR and HumaPen LUXURA HD, which are reusable mechanical pen-injectors with electronic display designed for use for the self-injection of insulin. Both are for use only with Humalog 3 mL insulin cartridges.
Additional information available to subscribers only: